Sources

Sources

  1. Pastuszak, Alexander W et al. “Comparison of the Effects of Testosterone Gels, Injections, and Pellets on Serum Hormones, Erythrocytosis, Lipids, and Prostate-Specific Antigen” Sexual medicine vol. 3,3 (2015): 165-73.

  2. “Benefits and Health Implications of Testosterone Therapy in Men With Testosterone Deficiency.” NeuroImage, Academic Press, 8 Nov. 2017, www.sciencedirect.com/science/article/pii/S2050052117301191.

  3. British Society for Sexual Medicine Guidelines on Adult ...www.bssm.org.uk/wp-content/uploads/2017/12/guidelines-on-adult-testosterone-deficiency-with-statements-for-uk-practice.pdf.

  4. British Society for Sexual Medicine2018-05-03T10. “BSSM ED Guideline.” Guidelines, 3 May 2018, www.guidelines.co.uk/mens-health/bssm-ed-guideline/454166.article.

  5. Carruthers, Malcolm. Androgen Deficiency in the Adult Male: Causes, Diagnosis and Treatment. AuthorHouse, 2016.

  6. “Clomiphene Citrate Treatment Outcomes in Taiwanese Hypogonadal Men: A Single-Center Preliminary Report.” NeuroImage, Academic Press, 13 May 2016, www.sciencedirect.com/science/article/pii/S1879522616300240.

  7. “Concomitant Intramuscular Human Chorionic Gonadotropin Preserves Spermatogenesis in Men Undergoing Testosterone Replacement Therapy.” NeuroImage, Academic Press, 20 Dec. 2012, www.sciencedirect.com/science/article/pii/S0022534712048677.

  8. Corona, Giovanni, et al. “EDEUS, a Real-Life Study on the Users of Phosphodiesterase Type 5 Inhibitors: Prevalence, Perceptions, and Health Care-Seeking Behavior Among European Men With a Focus on 2nd-Generation Avanafil.” Sexual Medicine, vol. 6, no. 1, 2018, pp. 15–23., doi:10.1016/j.esxm.2017.10.003.

  9. Coviello, A. D., et al. “Low Dose Human Chorionic Gonadotropin Maintains Intratesticular Testosterone In Normal Men Following Gonadotropin Suppression.” Journal of Investigative Medicine, vol. 52, 2004, doi:10.1097/00042871-200401001-00119.

  10. “Effects of Testosterone Treatment in Older Men.” New England Journal of Medicine, vol. 379, no. 15, Nov. 2018, pp. 1486–1486., doi:10.1056/nejmx180034.

  11. Elliott, Jesse, et al. “Testosterone Therapy in Hypogonadal Men: a Systematic Review and Network Meta-Analysis.” BMJ Open, British Medical Journal Publishing Group, 1 Nov. 2017, bmjopen.bmj.com/content/7/11/e015284.

  12. Hackett, Geoffrey Ian. “Erectile Dysfunction, Diabetes and Cardiovascular Risk.” British Journal of Diabetes, vol. 16, no. 2, 2016, p. 52., doi:10.15277/bjd.2016.076.

  13. Khera, Mohit, et al. “Adult-Onset Hypogonadism.” Mayo Clinic Proceedings, vol. 91, no. 7, 2016, pp. 908–926., doi:10.1016/j.mayocp.2016.04.022.

  14. Khourdaji, Iyad, et al. “The Future of Male Contraception: a Fertile Ground.” Translational Andrology and Urology, vol. 7, no. S2, 2018, doi:10.21037/tau.2018.03.23.

  15. Kim, Sun-Ouck, et al. “Penile Growth in Response to Human Chorionic Gonadotropin (HCG) Treatment in Patients with Idiopathic Hypogonadotrophic Hypogonadism.” Chonnam Medical Journal, vol. 47, no. 1, 2011, p. 39., doi:10.4068/cmj.2011.47.1.39.

  16. Korani, Mohamed Abdelraouf, and Ahmed Sonbol. “Study of Risk Factors for Erectile Dysfunction in Patients with Type 2 Diabetes Mellitus: Correlation to Serum Testosterone Level.” Alexandria Journal of Medicine, 2018, doi:10.1016/j.ajme.2018.01.002.

  17. La, Justin, et al. “Diet and Mens Sexual Health.” Sexual Medicine Reviews, vol. 6, no. 1, 2018, pp. 54–68., doi:10.1016/j.sxmr.2017.07.004.

  18. Lipshultz, Larryi, et al. “Preserving Fertility in the Hypogonadal Patient: an Update.” Asian Journal of Andrology, vol. 17, no. 2, 2015, p. 197., doi:10.4103/1008-682x.142772.

  19. Lo, Eric M., et al. “Alternatives to Testosterone Therapy: A Review.” Sexual Medicine Reviews, vol. 6, no. 1, 2018, pp. 106–113., doi:10.1016/j.sxmr.2017.09.004.

  20. Meikle, A.w. “High Serum Testosterone Is Associated With Reduced Risk of Cardiovascular Events in Elderly Men: The MrOS (Osteoporotic Fractures in Men) Study in Sweden.” Yearbook of Endocrinology, vol. 2012, 2012, pp. 300–302., doi:10.1016/j.yend.2012.03.013.

  21. Moon, Du Geon, et al. “AB018. Androgen Receptor CAG Repeat Length Polymorphism as a Risk Factor of Late Onset Hypogonadism/Metabolic Syndrome in a Korean Male Population.” Translational Andrology and Urology, vol. 6, no. S3, 2017, doi:10.21037/tau.2017.s018.

  22. Mulhall, John P., et al. “Evaluation and Management of Testosterone Deficiency: AUA Guideline.” The Journal of Urology, vol. 200, no. 2, 2018, pp. 423–432., doi:10.1016/j.juro.2018.03.115.

  23. Ohlander, Samuel J., et al. “Erythrocytosis Following Testosterone Therapy.” Sexual Medicine Reviews, vol. 6, no. 1, 2018, pp. 77–85., doi:10.1016/j.sxmr.2017.04.001.

  24. Rai, Jaskarn, and Tim Terry. “Comparison of Erectile Dysfunction Guidelines between the UK (BSSM/NICE) and Europe (EAU).” Journal of Clinical Urology, vol. 11, no. 2, 2018, pp. 122–126., doi:10.1177/2051415816688820.

  25. Ronde, Willem De, and Frank H De Jong. “Aromatase Inhibitors in Men: Effects and Therapeutic Options.” Reproductive Biology and Endocrinology, vol. 9, no. 1, 2011, p. 93., doi:10.1186/1477-7827-9-93.

  26. Simonelli, Chiara, et al. “Faculty of 1000 Evaluation for Hypoactive Sexual Desire Disorder: International Society for the Study of Womens Sexual Health (ISSWSH) Expert Consensus Panel Review.” F1000 - Post-Publication Peer Review of the Biomedical Literature, 2017, doi:10.3410/f.727073292.793531340.

  27. “Testosterone Therapy in Adult Men with Androgen Deficiency Syndromes.” 2013 Compendium of Clinical Practice Guidelines, 2013, pp. 504–531., doi:10.1210/ccpg.9781936704668.ch17.

  28. Thirumalai, Arthi, et al. “Treatment of Hypogonadism: Current and Future Therapies.” F1000Research, vol. 6, 2017, p. 68., doi:10.12688/f1000research.10102.1.

  29. Tirado, Laura C. Echeverri, et al. “Aging and Erectile Dysfunction.” Sexual Medicine Reviews, vol. 4, no. 1, 2016, pp. 63–73., doi:10.1016/j.sxmr.2015.10.011.

  30. Traish, A., Goldstein, I. and Kim, N. (2007). Testosterone and Erectile Function: From Basic Research to a New Clinical Paradigm for Managing Men with Androgen Insufficiency and Erectile Dysfunction. European Eurology, 52(1), pp.54-70

  31. Wenker, Evan P., et al. “The Use of HCG-Based Combination Therapy for Recovery of Spermatogenesis after Testosterone Use.” The Journal of Sexual Medicine, vol. 12, no. 6, 2015, pp. 1334–1337., doi:10.1111/jsm.12890.

  32. Zhu, Da-Long, et al. “The Effectiveness of Zinc Supplementation in Men with Isolated Hypogonadotropic Hypogonadism.” Asian Journal of Andrology, vol. 19, no. 3, 2017, p. 280., doi:10.4103/1008-682x.189621.